We are live on ! Find out more
HAO icon

Haoxi Health Technology

1 hedge funds and large institutions have $20.6K invested in Haoxi Health Technology in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.07% less ownership

Funds ownership: 1.96% → 0.89% (-1.1%)

67% less funds holding

Funds holding: 3 → 1 (-2)

89% less capital inflows, than outflows

Capital inflows: $3.22K | Capital outflows: $28.8K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

HAO Hedge Fund Activity: Q1 2026 in Review

1 of the 8,244 institutional investors tracked by Wall St. Rank reported a position in Haoxi Health Technology (HAO) for Q1 2026, worth a combined $20.6K — down 56% from $46.4K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of HAO and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was XTX Topco, adding an estimated $3.22K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $15.8K sold.

  • 1 institutional investor held Haoxi Health Technology (HAO) as of Q1 2026, down from 3 in Q4 2025.
  • Funds reported $20.6K of Haoxi Health Technology stock for Q1 2026, down 56% quarter-over-quarter.
  • 0 funds opened new Haoxi Health Technology positions in Q1 2026 and 2 closed out, a net change of -2 holders.
  • The largest Haoxi Health Technology buyer in Q1 2026 was XTX Topco, an estimated $3.22K added.
  • The largest Haoxi Health Technology seller in Q1 2026 was Two Sigma Securities, an estimated $15.8K sold.

Based on aggregated 13F filings for Q1 2026.